(D-Pro2,D-Trp7·9)-Substance P
CAS No. 80434-86-2
(D-Pro2,D-Trp7·9)-Substance P ( ——— )
产品货号. M40451 CAS No. 80434-86-2
[D-Pro2,D-Trp7,9] Substance P,是 Substance P 的类似物,是一种弱激动剂,是一种有效的、特异性、竞争性的 Substance P 拮抗剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 25MG | 获取报价 | 有现货 |
|
| 50MG | 获取报价 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称(D-Pro2,D-Trp7·9)-Substance P
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述[D-Pro2,D-Trp7,9] Substance P,是 Substance P 的类似物,是一种弱激动剂,是一种有效的、特异性、竞争性的 Substance P 拮抗剂。
-
产品描述[D-Pro2,D-Trp7,9] Substance P, a Substance P analogue, is a weak agonist and a potent, specific, competitive Substance P antagonist.
-
体外实验[D-Pro2,D-Trp7,9] Substance P (0-30 nmol, Intravitreal injection) greatly reduces not only the effects of exogenous Substance P but also the inflammatory response to trauma to the eye.[D-Pro2,D-Trp7,9] Substance P specifically antagonizes the contractile effects of Substance P on the guinea-pig isolated taenia coli.Animal Model:Adult pigmented rabbits (1.5-3 kg) Dosage:0.03, 0.3, 3, and 30 nmol Administration: Intravitreal injection or topical application onto the eye, 60 μL Result:Reduced the inflammatory response to Substance P. Dependently reduced the inflammatory response to infrared irradiation. In itself, intravitreal injection of low doses of [D-Pro2, D-Trp7'9]SP had no effects on the eye.
-
体内实验[D-Pro2,D-Trp7,9] Substance P decreases proliferation only in a few cell lines, and only in the highest concentration (100 μM). [D-Pro2,D-Trp7,9] Substance P displays a significantly weaker antiproliferative action than Aprepitant on cancer or normal cell lines.
-
同义词———
-
通路Others
-
靶点Other Targets
-
受体———
-
研究领域———
-
适应症———
化学信息
-
CAS Number80434-86-2
-
分子量1515.86
-
分子式C74H106N20O13S
-
纯度>98% (HPLC)
-
溶解度———
-
SMILES———
-
化学全称———
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
Antioxidant peptide ...
Antioxidant peptide A is a short peptide, which contains alternative aromatic or sulfur-containing amino acid.
-
JG-2016
JG-2016 是一种有效的组蛋白乙酰转移酶 1 (HAT1) 抑制剂,在 HAT1 乙酰化检测中 IC50 为 14.8 μM[1]。
-
ATI-2341 TFA (133787...
ATI-2341 is an effective functionally selective allosteric agonist for the c-x-c chemokine receptor type 4 (CXCR4), which ACTS as a biased ligand in favor of G G G G G 1 activation instead of G G G G G 13.ATI-2341 activates the inhibitory heterotrimer G protein (Gi) to promote inhibition of cAMP production and induce calcium mobilization.ATI-2341 is an effective mobilization agent for myeloid polymorphonuclear neutrophils (PMNs) and hematopoietic stem and progenitor cells (HSPCs).
021-51111890
购物车()
sales@molnova.cn

